Patents by Inventor Scott Eliasof

Scott Eliasof has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200093932
    Abstract: Provided are methods relating to the treatment of cancer with a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101 in combination with an inhibitor of the tryptophan metabolism pathway, e.g., an indoleamine-2,3-dioxygenase (IDO) inhibitor or a tryptophan-2, 3-dioxygenase (TDO) inhibitor.
    Type: Application
    Filed: December 1, 2017
    Publication date: March 26, 2020
    Inventors: Paul Friedman, Scott Eliasof, Adrian Senderowicz, Andres Tellez, Douglas Lazarus, Lata Jayaraman
  • Publication number: 20200046845
    Abstract: Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of a disease or disorder, e.g., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
    Type: Application
    Filed: June 24, 2019
    Publication date: February 13, 2020
    Inventor: Scott Eliasof
  • Publication number: 20180193486
    Abstract: Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
    Type: Application
    Filed: October 10, 2017
    Publication date: July 12, 2018
    Inventor: Scott Eliasof
  • Publication number: 20170368194
    Abstract: Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of a disease or disorder, e.g., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
    Type: Application
    Filed: April 5, 2017
    Publication date: December 28, 2017
    Inventor: Scott Eliasof
  • Publication number: 20160101185
    Abstract: Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
    Type: Application
    Filed: May 12, 2015
    Publication date: April 14, 2016
    Applicant: CERULEAN PHARMA INC.
    Inventors: Edward G. Garmey, Scott Eliasof
  • Publication number: 20160058874
    Abstract: Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of a disease or disorder, e.g., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
    Type: Application
    Filed: March 25, 2015
    Publication date: March 3, 2016
    Applicant: CERULEAN PHARMA INC.
    Inventor: Scott Eliasof
  • Publication number: 20150209440
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: April 9, 2015
    Publication date: July 30, 2015
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald E. Bergstrom
  • Publication number: 20150005230
    Abstract: Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of a disease or disorder, e.g., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
    Type: Application
    Filed: January 30, 2014
    Publication date: January 1, 2015
    Applicant: CERULEAN PHARMA INC.
    Inventor: Scott Eliasof
  • Publication number: 20140296322
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: April 18, 2014
    Publication date: October 2, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Jungyeon Hwang, Donald Bergstrom
  • Publication number: 20140286873
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 25, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Thomas C. Crawford, Scott Eliasof, Geeti Gangal, Pei-Sze Ng, Lawrence Alan Reiter
  • Publication number: 20140255374
    Abstract: Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
    Type: Application
    Filed: November 6, 2013
    Publication date: September 11, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventor: Scott Eliasof
  • Publication number: 20140193510
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: February 13, 2014
    Publication date: July 10, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Thomas C Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • Publication number: 20140105891
    Abstract: Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
    Type: Application
    Filed: October 4, 2013
    Publication date: April 17, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Edward G. Garmey, Scott Eliasof
  • Publication number: 20140099263
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: March 19, 2013
    Publication date: April 10, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Thomas C. Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • Publication number: 20140072633
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer or neurological deficits. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: May 29, 2013
    Publication date: March 13, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Thomas C. Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • Publication number: 20140037573
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: February 21, 2013
    Publication date: February 6, 2014
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald Bergstrom
  • Publication number: 20130011445
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: July 12, 2012
    Publication date: January 10, 2013
    Inventors: Thomas C. Crawford, Scott Eliasof, Geeti Gangal, Pei-Sze Ng, Lawrence Alan Reiter
  • Publication number: 20120302622
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: April 10, 2012
    Publication date: November 29, 2012
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald E. Bergstrom
  • Publication number: 20120282306
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 8, 2012
    Inventors: Scott Eliasof, Thomas C. Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • Publication number: 20120225129
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: August 18, 2011
    Publication date: September 6, 2012
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald E. Bergstrom